首页/数据集/Summary of ozanezumab PK/PD model parameters.

Summary of ozanezumab PK/PD model parameters.

NIAID Data Ecosystem2026-03-08 收录

药效动力学

药物参数估计

数据链接：

https://figshare.com/articles/dataset/_Summary_of_ozanezumab_PK_PD_model_parameters_/1315659 数据链接链接失效反馈

官方服务：

资源简介：

RSE: Parameter Estimation Standard Error/Parameter Estimate Summary of ozanezumab PK/PD model parameters.

应用场景：

创建时间：

2015-02-23

儿科心血管药物试验

药效动力学

Additional vital signs taken during the open-label period, including pulse, blood pressure, and mean arterial pressure Study Description A Phase II, randomized, double-blind, withdrawal to placebo stu

NIAID Data Ecosystem60

EC50 values (nM) for IR activation and relative activation compared to IR-B.

胰岛素受体

药效动力学

EC50 values (nM) for IR activation and relative activation compared to IR-B.

NIAID Data Ecosystem50

The P valve of variable factors on PK and BP change parameters in the corrected models.

代谢动力学

药效动力学

Data were shown as mean±SD;*P**PORM1, orosomucoid 1; ABCC2, ATP-binding cassette, sub-family C, member 2; ABCG2, ATP-binding cassette, sub-family G, member 2; ABCB1, ATP-binding cassette, sub-family B

Figshare2015-12-02 更新30

Pharmackinetics/pharmacodynamics of ceftazidime-avibactam in adult critically ill patients receiving continuous renal replacement therapy

药效动力学

肾脏替代治疗

Ceftazidime-avibactam (CAZ-AVI), a novel antibiotic, is effective in treating infections caused by carbapenem-resistant Gram-negative bacteria. However, in patients receiving continuous renal replacem

DataONE2025-11-28 更新50

JAKEE Pharmacodynamic Data

药效动力学

流式细胞术

Flow cytometry-based pharmacodynamic source data to accompany the primary results in the mansucript.

DataCite Commons2022-05-19 更新40